Evidence map›Paper›PMID 28538739›Full record

ArticleNature protocols2017

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples.

Joshua Quick, Nathan D Grubaugh, Steven T Pullan, Ingra M Claro, Andrew D Smith, Karthik Gangavarapu, Glenn Oliveira, Refugio Robles-Sikisaka, Thomas F Rogers, Nathan A Beutler and 18 more

Registry-linked trialAbstract read
In one paragraph

Article in Nature protocols, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07626073 (h Can Provide the Detection Results of Pathogen Type and Resistant Gene. This Study is a Prospective Multi Centers Study to Explore Using the New Diagnostic Tool of " RPIP " and the Different Detection Methods of Next Generation Sequencing and Multiplex PC R in Patients With Pneumonia in ICU. Further Compare the Difference of Pathogen Identification and Clinical Impact by Different Diagnostic Methods.), which is not on this map. Cited by 759 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
759citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07626073 enrolling by invitationnot on this mapstarted 2023, after this paper: background citation

h Can Provide the Detection Results of Pathogen Type and Resistant Gene. This Study is a Prospective Multi Centers Study to Explore Using the New Diagnostic Tool of " RPIP " and the Different Detection Methods of Next Generation Sequencing and Multiplex PC R in Patients With Pneumonia in ICU. Further Compare the Difference of Pathogen Identification and Clinical Impact by Different Diagnostic Methods.

Typeobservational_patient_registrySponsorChina Medical University HospitalRan2023 to 2028Enrolled200ConditionsRespiratory Pathogens
3 · Its place in the literature

Who cites it

759 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Machine-Learning Microfluidic Minute-Scale Microorganism Metrics Monitoring(M6).Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  18. Article
  19. Review
  20. Article

699 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Joshua QuickInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, UK.
Nathan D GrubaughThe Scripps Research Institute, La Jolla, California, USA.ORCID http://orcid.org/0000-0003-2031-1933
Steven T PullanPublic Health England, National Infection Service, Porton Down, Salisbury, UK.
Ingra M ClaroDepartment of Infectious Disease and Institute of Tropical Medicine, University of Saõ Paulo, Saõ Paulo, Brazil.
Andrew D SmithInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, UK.
Karthik GangavarapuThe Scripps Research Institute, La Jolla, California, USA.
Glenn OliveiraScripps Translational Science Institute, La Jolla, California, USA.
Refugio Robles-SikisakaThe Scripps Research Institute, La Jolla, California, USA.
Thomas F RogersThe Scripps Research Institute, La Jolla, California, USA.
Nathan A BeutlerThe Scripps Research Institute, La Jolla, California, USA.
Dennis R BurtonThe Scripps Research Institute, La Jolla, California, USA.
Lia Laura Lewis-XimenezInstituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Jaqueline Goes de JesusFundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.
Marta GiovanettiFundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.
Sarah C HillDepartment of Zoology, University of Oxford, Oxford, UK.
Allison BlackVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.ORCID http://orcid.org/0000-0002-6618-4127
Trevor BedfordVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Miles W CarrollPublic Health England, National Infection Service, Porton Down, Salisbury, UK.
Marcio NunesInstituto Evandro Chagas, Belem, Brazil.
Luiz Carlos AlcantaraFundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.ORCID http://orcid.org/0000-0002-6769-9931
Ester C SabinoDepartment of Infectious Disease and Institute of Tropical Medicine, University of Saõ Paulo, Saõ Paulo, Brazil.
Sally A BaylisPaul-Ehrlich-Institut, Langen, Germany.
Nuno R FariaDepartment of Zoology, University of Oxford, Oxford, UK.
Matthew LooseDeepSeq, School of Life Sciences, University of Nottingham, Nottingham, UK.
Jared T SimpsonOICR, Toronto, Canada.
Oliver G PybusDepartment of Zoology, University of Oxford, Oxford, UK.
Kristian G AndersenThe Scripps Research Institute, La Jolla, California, USA.
Nicholas J LomanInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, UK.

Funding

Scripps Translational Science InstituteUL1TR001114 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2013 to 2017
$24.0M
Understanding Transmission with Integrated Genetic and Epidemiologic InferenceU54GM111274 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VESPIGNANI, ALESSANDRO · 2014 to 2018
$12.5M
PATHOGENESIS AND IMMUNOLOGY OF DISEASET32AI007244 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1985 to 2022
$8.8M
Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigationR35GM119774 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDFORD, TREVOR BC · 2016 to 2025
$4.1M
Medical Research Council MC_PC_15100Medical Research Council MR/L015080/1Medical Research Council MR/M501621/1NCATS NIH HHS UL1 TR001114NIAID NIH HHS T32 AI007244NIGMS NIH HHS R35 GM119774NIGMS NIH HHS U54 GM111274Wellcome Trust
6 · The paper itself

Abstract

Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing directly from clinical samples (i.e., without isolation and culture) remains challenging for viruses such as Zika, for which metagenomic sequencing methods may generate insufficient numbers of viral reads. Here we present a protocol for generating coding-sequence-complete genomes, comprising an online primer design tool, a novel multiplex PCR enrichment protocol, optimized library preparation methods for the portable MinION sequencer (Oxford Nanopore Technologies) and the Illumina range of instruments, and a bioinformatics pipeline for generating consensus sequences. The MinION protocol does not require an Internet connection for analysis, making it suitable for field applications with limited connectivity. Our method relies on multiplex PCR for targeted enrichment of viral genomes from samples containing as few as 50 genome copies per reaction. Viral consensus sequences can be achieved in 1-2 d by starting with clinical samples and following a simple laboratory workflow. This method has been successfully used by several groups studying Zika virus evolution and is facilitating an understanding of the spread of the virus in the Americas. The protocol can be used to sequence other viral genomes using the online Primal Scheme primer designer software. It is suitable for sequencing either RNA or DNA viruses in the field during outbreaks or as an inexpensive, convenient method for use in the lab.

Indexed as

Genome, ViralDNA VirusesMolecular EpidemiologyMultiplex Polymerase Chain ReactionRNA VirusesSequence Analysis, DNA

Identifiers

PMID28538739
PMCPMC5902022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.